Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001209191-19-038866

Director acquired 16,377 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kazam Joshua A · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2019-06-06 Grant or award : show line 1 in the form +16,377 1,407,028 D
Loading xslF345X03/doc4.xml…